Nigeria: 54gene creating trust for Africa from future proceeds of drug discovery programme

African health technology company, 54gene, is creating a trust which it will use to invest up to 5% of future proceeds from the company’s commercial drug discovery programme. The company is focused on creating a pipeline of drugs based on insights drawn from the healthcare and research ecosystem in Africa, to the benefit of 1.5…

You must be a HMI Subscriber to view this content.

Subscribe Now »